Literature DB >> 535

[Regulation of interrelation between pulmonary ventilation and circulation].

V A Volyntseva, G I Kositskiĭ, V S Kupriianov.   

Abstract

In acute experiments on 92 cats anesthetized with Urethane and kept under controlled respiration the mechanism of tonic activity of the pulmonary vessels was studied in the presence of a decreased partial pressure of oxygen in the alveoli. The tonicity of the pulmonary vessels was recorded during autoperfusion of the vessels of the posterior lobe of the left lung by means of a perfusion pump. Simultaneously, the pressure in the common carotid artery was recorded and the oxygen saturation of the blood was measured. Pharmacological analysis was used for the study of the mechanism of the pressor reaction of the pulmonary vessels under hypoxic hypoxy, and it demonstrated that the pression of the pulmonary vessels that develops under alveolar hypoxy is less distinct under the effect of the ganglioblocking agent Benzo-hexonium, as well as the myotropic agents Papaverine and Chloracizine. The above reaction was significantly inhibited by the blocking agents of the D- and M-serotonin-reactive structures -- Dihydroergothamine, Morphine and Novocain, and it was completely lacking against the background of the action of Izadrine and Dimedrol -- blocking agents of serotonin- and histamine-reactive structures. It can be supposed that the D- and M-serotonin-reactive, and probably also the histamine-reactive structures participate in the regulation of the interrelationship of ventilation and pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 535

Source DB:  PubMed          Journal:  Kardiologiia        ISSN: 0022-9040            Impact factor:   0.395


  5 in total

Review 1.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Marcella M Johnson; Shamim Ejaz; Mouhammed Amir Habra; Thereasa Rich; Naifa Busaidy; Gilbert J Cote; Nancy Perrier; Alexandria Phan; Shreyaskumar Patel; Steven Waguespack; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

3.  Genetic testing in pheochromocytoma or functional paraganglioma.

Authors:  Laurence Amar; Jérôme Bertherat; Eric Baudin; Christiane Ajzenberg; Brigitte Bressac-de Paillerets; Olivier Chabre; Bernard Chamontin; Brigitte Delemer; Sophie Giraud; Arnaud Murat; Patricia Niccoli-Sire; Stéphane Richard; Vincent Rohmer; Jean-Louis Sadoul; Laurence Strompf; Martin Schlumberger; Xavier Bertagna; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

4.  Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.

Authors:  Laurence Amar; Eric Baudin; Nelly Burnichon; Séverine Peyrard; Stéphane Silvera; Jérôme Bertherat; Xavier Bertagna; Martin Schlumberger; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo; Pierre-François Plouin
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

Review 5.  The genetics of phaeochromocytoma: using clinical features to guide genetic testing.

Authors:  Mariam Jafri; Eamonn R Maher
Journal:  Eur J Endocrinol       Date:  2011-09-06       Impact factor: 6.664

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.